Anti-TNF-alpha antibodies and their uses

Details for Australian Patent Application No. 2010236256 (hide)

Owner Abbott Biotherapeutics Corp.

Inventors Harding, Fiona A.; Akamatsu, Yoshiko; Dubridge, Robert B.; Powers, David B.

Agent Davies Collison Cave

Pub. Number AU-A-2010236256

PCT Pub. Number WO2010/121140

Priority 61/170,053 16.04.09 US

Filing date 16 April 2010

Wipo publication date 21 October 2010

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

3 November 2011 PCT application entered the National Phase

  PCT publication WO2010/121140 Priority application(s): WO2010/121140

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010236257-Compositions and methods to treat acute myelogenous leukemia

2010236248-Digital creative interaction system